A Prospective Observational Study Combinition of Proton Pump Inhibitors with Prokinetics in Gerd
Authors:
- Zobia MushtaqZMZobia Mushtaq
- Tanveer HussainTHTanveer Hussain
- Imran JoherIJImran Joher
Open Access
- 30 September 2022
- journal article
- research article
- Published by Lahore Medical and Dental College
- Vol. 16 (9) , 427-429
Abstract
Background: Gastroesophageal reflux disease (GERD), a fairly common ailment that has a negative influence on quality of life. 30- 40% of patients with GERD have an insufficient response to standard PPIs therapy. For subjects resistant to this PPI therapy, double the PPI dosage or switch to different PPIs, which may not be ideal. So, combination therapy with prokinetic agent will significantly improve GERD symptoms. Study Design: A prospective observational study. Place and Duration: In the Department of Medicine, Faisalabad Medical University, Faisalabad from May 2022 to July 2022. Material and methods: 130 patients with suggestive symptoms of GERD were included to evaluate overlap between GERD and delayed gastric emptying and to forecast the necessity for therapy in combination with prokinetic drugs using the Frequency Scale for the Symptoms of GERD (FSSG) score. Results: 17.20 ± 8.40 was the mean total score of FSSG. Of the 130 subjects, 106 (81.54%) patients have GERD symptoms with an overall FSSG score >8. 7.43 ± 4.08 was the mean reflux score, and 9.40 ± 5.30 was the mean dysmotility score. In this analysis, patients with GERD symptoms had high score of FSSG, the symptoms of dysmotility appeared to be the main symptom than acid reflux. Conclusions: Based on this analysis results, combination therapy with prokinetic and PPIs in the subgroups of subjects with high scores of FSSG improved GERD symptoms. Keywords: Dysmotility score, delayed gastric emptying, GERD and Reflux score.Keywords
This publication has 12 references indexed in Scilit:
- Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective studyScientific Reports, 2020
- Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the TruthGastroenterology, 2019
- Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux SymptomsDigestive Diseases and Sciences, 2018
- Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: A meta-analysisWorld Journal of Gastroenterology, 2014
- Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux diseaseWorld Journal of Gastroenterology, 2013
- Dexlansoprazole: A proton pump inhibitor with a dual delayed-release systemClinical Therapeutics, 2010
- Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapyJournal of Gastroenterology and Hepatology, 2007
- Review article: the opportunities and benefits of extended acid suppressionAlimentary Pharmacology & Therapeutics, 2006
- Clinical Response (Remission of Symptoms) in Erosive and Non-Erosive Gastro-Oesophageal Reflux DiseaseDrugs, 2005
- Impact of Delayed Gastric Emptying on the Outcome of Antireflux SurgeryAnnals of Surgery, 2001